Canadian Clinical Trials Asset Map: released on June 4 and featured in CMAJ

The Canadian Clinical Trials Asset Map (CCTAM) was recently featured in an article by the Canadian Medical Association Journal (CMAJ). You can access the article here.  The CCTAM website went live June 4 with over 800 database records, and it is expected to grow. The map provides information on conditions and diseases being studied, and identifies gaps.  www.base.cctam.ca

cctcc-logo

The Canadian Clinical Trials Coordinating Centre was created to implement an action plan to strengthen and improve clinical trials in Canada and streamline processes for companies and researchers.

Developed through extensive stakeholder consultation, the action plan includes nine key recommendations to improve the coordination of clinical trials in Canada, increase participation in trials, and strategically raise Canada’s profile among international companies. Those recommendations are summarized in the report “To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada.”

The CCTCC is a collaborative effort of the Canadian Institutes of Health Research (CIHR), Canada’s Research-Based Pharmaceutical Companies (Rx&D), and HealthCareCAN.

Advertisements